Patents by Inventor Suyeon YEOM

Suyeon YEOM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250115562
    Abstract: The present disclosure relates to a method for preparing aryl 2-tetrazol-2-yl ketone of the following Formula 1a with improved selectivity: wherein R1 and R2 are the same as defined herein.
    Type: Application
    Filed: December 16, 2024
    Publication date: April 10, 2025
    Inventors: Kyuwoong LEE, Kyungmi CHA, Suyeon YEOM, Jiseon WOO
  • Publication number: 20220112167
    Abstract: The present disclosure relates to a method for preparing aryl 2-tetrazol-2-yl ketone of the following Formula 1a with improved selectivity: wherein R1 and R2 are the same as defined herein.
    Type: Application
    Filed: December 20, 2021
    Publication date: April 14, 2022
    Inventors: Kyuwoong LEE, Kyungmi CHA, Suyeon YEOM, Jiseon WOO
  • Patent number: 11236054
    Abstract: The present disclosure relates to a method for preparing aryl 2-tetrazol-2-yl ketone of the following Formula 1a with improved selectivity: wherein R1 and R2 are the same as defined herein.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: February 1, 2022
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Kyuwoong Lee, Kyungmi Cha, Suyeon Yeom, Jiseon Woo
  • Publication number: 20210122719
    Abstract: The present disclosure relates to a method for preparing aryl 2-tetrazol-2-yl ketone of the following Formula 1a with improved selectivity: wherein R1 and R2 are the same as defined herein.
    Type: Application
    Filed: February 27, 2020
    Publication date: April 29, 2021
    Inventors: Kyuwoong LEE, Kyungmi CHA, Suyeon YEOM, Jiseon WOO
  • Patent number: 10611737
    Abstract: The present disclosure relates to a method for preparing aryl 2-tetrazol-2-yl ketone of the following Formula 1a with improved selectivity: wherein R1 and R2 are the same as defined herein.
    Type: Grant
    Filed: October 24, 2019
    Date of Patent: April 7, 2020
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Kyuwoong Lee, Kyungmi Cha, Suyeon Yeom, Jiseon Woo
  • Patent number: 9422274
    Abstract: The present invention relates to oxazolidinone compounds represented by Chemical Formula 1, pharmaceutically acceptable salts thereof or hydrates, a method of preparing the same, and a pharmaceutical composition for preventing or treating Hepatitis C infection: Wherein R1, R7 and X are defined in the detailed description.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: August 23, 2016
    Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Sung Key Jang, Gyo Chang Keum, Eunice Eun-Kyeong Kim, Soon Bang Kang, Suyeon Yeom, Juhyeon Lee, SeungGi Lee, Hee Sun Kim
  • Publication number: 20150148386
    Abstract: The present invention relates to oxazolidinone compounds represented by Chemical Formula 1, pharmaceutically acceptable salts thereof or hydrates, a method of preparing the same, and a pharmaceutical composition for preventing or treating Hepatitis C infection: Wherein R1, R7 and X are defined in the detailed description.
    Type: Application
    Filed: November 12, 2014
    Publication date: May 28, 2015
    Applicants: POSTECH ACADEMY-INDUSTRY FOUNDATION, KOREA INSTITITE OF SCIENCE AND TECHNOLOGY
    Inventors: Sung Key JANG, GYO CHANG KEUM, Eunice Eun-Kyeong KIM, Soon Bang KANG, Suyeon YEOM, Juhyeon LEE, SeongGi LEE, HEE SUN KIM